Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Patient Outcomes after Initial High Dose Versus Low Dose Romiplostim for Inpatient Management of Immune Thrombocytopenia

Elizabeth King, Uzo Abajue, Amanda Pawlenty, Huong Lan Truong, Sabrina Fischer, Alexandra P. Wolanskyj-Spinner, Rajiv K. Pruthi, Carl C. Hook, Animesh D. Pardanani, Aneel Ashrani, Ewa Wysokinska, Surbhi Shah, Ronald S. Go

Blood (2023) 142 (Supplement 1): 393.

https://doi.org/10.1182/blood-2023-180279

Published: 2023

Journal Articles

C3+ and C3- Warm Autoimmune Hemolytic Anemias: A Comparison of Clinical Characteristics and Treatment Outcomes

Jordan Nunnelee, Jithma Prasad Abeykoon, Aneel Ashrani, Michelle Ann Elliott, Carl C. Hook, Animesh D. Pardanani, Rajiv K. Pruthi, Rachelle Rouse, Meera Sridharan, Alexandra P. Wolanskyj-Spinner, Ronald S. Go

Blood (2023) 142 (Supplement 1): 5195.

https://doi.org/10.1182/blood-2023-174805

Published: 2023

Journal Articles

Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia

John McGlothlin, Jithma P. Abeykoon, Eyad Al-Hattab, Aneel A. Ashrani, Michelle A Elliott, Ronald Go, C. Christopher Hook, Animesh Pardanani, Rajiv K. Pruthi, Meera Sridharan, Alexandra P. Wolanskyj

Blood (2022) 140 (Supplement 1): 5328–5330.

https://doi.org/10.1182/blood-2022-159270

Published: 2022

Journal Articles

Cytogenetics in Essential Thrombocythemia: Phenotype and Molecular Correlates and Prognostic Relevance in 818 Informative Cases

Naseema Gangat, Jaya Kittur, Yamna Jadoon, Natasha Szuber, Curtis A. Hanson, Alexandra P. Wolanskyj, Rhett P. Ketterling, Ayalew Tefferi

Blood (2021) 138 (Supplement 1): 3629.

https://doi.org/10.1182/blood-2021-152549

Published: 2021

Journal Articles

The 1.5 Million Platelet Count Threshold in Essential Thrombocythemia: Phenotype and Genotype Correlates and Relevance to Vascular Events

Naseema Gangat, Natasha Szuber, Yamna Jadoon, Faiqa Farrukh, Elena Rossi, Francesco Ramundo, Curtis A. Hanson, Alexandra P. Wolanskyj, Animesh D. Pardanani, Valerio De Stefano, Alessandro M. Vannucchi, Tiziano Barbui, Ayalew Tefferi

Blood (2021) 138 (Supplement 1): 3630.

https://doi.org/10.1182/blood-2021-149223

Published: 2021

Journal Articles

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-139050

Published: 2020

Journal Articles

Immune-Related Hematologic Adverse Events in the Context of Checkpoint Inhibitors

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-138657

Published: 2020

Journal Articles

Utility and Patterns of Vitamin B12 and Folate Testing in Patients with Isolated Thrombocytopenia

Emma P. DeLoughery, Aishwarya Ravindran, MBBS, Aneel A. Ashrani, MD MS, Kebede H. Begna, MD, C. Christopher Hook, MD, Ariela L. Marshall, MD, Rajiv K Pruthi, MBBS, Alexandra P. Wolanskyj-Spinner, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 5589.

https://doi.org/10.1182/blood.V130.Suppl_1.5589.5589

Published: 2017

Journal Articles

Extreme Thrombocytosis: Influence of Care Setting and Likelihood of Occult Malignancy

Ronan W. Hsieh, MD, Aishwarya Ravindran, MBBS, C. Christopher Hook, MD, Rajiv K. Pruthi, MBBS, Ariela L. Marshall, MD, Aneel A. Ashrani, MD, Kebede H. Begna, MD, Timothy G. Call, MD, William J. Hogan, MBBCh, Mark R. Litzow, MD, James D. Hoyer, MD, Jennifer L. Oliveira, MD, Prakash Vishnu, MD FACP, Ayalew Tefferi, MD, Michelle A. Elliott, MD, Aref Al-Kali, MD, Alexandra P. Wolanskyj-Spinner, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 1644.

https://doi.org/10.1182/blood.V130.Suppl_1.1644.1644

Published: 2017

Journal Articles

Clinical and Serological Characteristics of Cold Autoimmune Hemolytic Anemia with Concomitant Cold Agglutinin and Donath-Landsteiner Antibodies

Aishwarya Ravindran, MBBS, Eapen K. Jacob, MD, Justin D. Kreuter, Sheila K. Moldenhauer, SBB (ASCP), Rajiv K. Pruthi, MBBS, C. Christopher Hook, MD, Timothy G. Call, MD, Alexandra P. Wolanskyj-Spinner, MD, Ariela L. Marshall, MD, Aneel A. Ashrani, MD, Kebede H. Begna, MD, Neil E. Kay, MD, Jeffrey L. Winters, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 927.

https://doi.org/10.1182/blood.V130.Suppl_1.927.927

Published: 2017

Journal Articles

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Jennifer Yui, MD, Mythri Mudireddy, MBBS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle Elliott, MD, William J. Hogan, MBChB, C. Christopher Hook, MD, Alexandra P Wolanskyj, MD, Mark R. Litzow, MD, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Kebede H. Begna, MD

Blood (2016) 128 (22): 2798.

https://doi.org/10.1182/blood.V128.22.2798.2798

Published: 2016

Journal Articles

Accessory Splenectomy for Relapsed Idiopathic Thrombocytopenic Purpura.

Gita Thanarajasingam, Bsc, Alexandra P. Wolanskyj, M.D., Robert L. Phyliky, M.D., Dirk R. Larson, M.S.

Blood (2007) 110 (11): 3213.

https://doi.org/10.1182/blood.V110.11.3213.3213

Published: 2007

Journal Articles

Choosing the Right Patients for Clinical Trials in Essential Thrombocythemia or Polycythemia Vera: Leukemic or Fibrotic Transformation Risk Assessment among 1061 Patients from a Single Institution.

Ayalew Tefferi, MD, Naseema Gangat, MD, Alexandra P. Wolanskyj, MD, Susan M. Schwager, Animesh Pardanani, MD, PhD, Ruben A. Mesa, MD, Rebecca F. McClure, MD, Chin-Yang Li, MD, Curtis A. Hanson, MD

Blood (2007) 110 (11): 3546.

https://doi.org/10.1182/blood.V110.11.3546.3546

Published: 2007

Journal Articles

A Study of Bedside Visual Art To Decrease Anxiety and Improve Pain and Mood in Cancer Patients: The Mayo Clinic Experience.

Alexandra P. Wolanskyj, MD, Elizabeth A. Curry, M.A., Shawna L. Ehlers, Ph.D., Debra M. Eagle, MBA, Dirk R. Larson, M.S., Colin L. Colby, M.S., Brent A. Bauer, M.D., Paul D. Scanlon, M.D.

Blood (2007) 110 (11): 975.

https://doi.org/10.1182/blood.V110.11.975.975

Published: 2007

Journal Articles

Cytogenetic Abnormalities in Essential Thrombocythemia: Prevalence and Prognostic Significance.

Alexandra P. Wolanskyj, MD, Naseema Gangat, MD, Susan M. Schwager, CSA, Rhett P. Ketterling, MD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 3626.

https://doi.org/10.1182/blood.V108.11.3626.3626

Published: 2006

Journal Articles

MPL 515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

Animesh D. Pardanani, Ross L. Levine, Terra Lasho, Yana Pikman, Ruben A. Mesa, Martha Wadleigh, David P. Steensma, Michelle A. Elliott, Alexandra P. Wolanskyj, William J. Hogan, Rebecca F. McClure, Mark R. Litzow, D. Gary Gilliland, Ayalew Tefferi

Blood (2006) 108 (10): 3472–3476.

https://doi.org/10.1182/blood-2006-04-018879

Published: 2006

Journal Articles

Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?

Ayalew Tefferi, Naseema Gangat, Alexandra P. Wolanskyj

Blood (2006) 108 (7): 2493–2494.

https://doi.org/10.1182/blood-2006-05-025544

Published: 2006

Journal Articles

JAK2 V617F Mutation in Essential Thrombocythemia: Clinical Associations and Long-Term Prognostic Relevance.

Alexandra P. Wolanskyj, MD, Terra L. Lasho, MT, ASCP, Susan M. Schwager, Rebecca F. McClure, MD, Martha Wadleigh, MD, Stephanie J. Lee, MD, D. Gary Gilliland, MD, PhD, Ayalew Tefferi, MD

Blood (2005) 106 (11): 254.

https://doi.org/10.1182/blood.V106.11.254.254

Published: 2005

Journal Articles

Lenalidomide (CC-5013) Treatment for Anemia Associated with Myelofibrosis with Myeloid Metaplasia.

Ayalew Tefferi, MD, Ruben A. Mesa, MD, William J. Hogan, MD, Trudy A. Shaw, Gayle E. Reyes, Jacob B. Allred, Cynthia X. Ma, MD, Grace K. Dy, MD, Alexandra P. Wolanskyj, MD, Mark L. Litzow, MD, David P. Steensma, MD, Timothy G. Call, MD, Rebecca F. McClure, MD

Blood (2005) 106 (11): 2583.

https://doi.org/10.1182/blood.V106.11.2583.2583

Published: 2005

Journal Articles

Low Incidence of FIP1L1-PDGFRA in Eosinophilic Patients and Long-Term Experience with Imatinib Therapy.

Animesh D. Pardanani, MD, PhD, Rhett P. Ketterling, MD, Chin-Yang Li, MD, Alexandra P. Wolanskyj, MD, Michelle A. Elliott, MD, John K. Camoriano, MD, Joseph H. Butterfield, MD, Gordon W. Dewald, PhD, Ayalew Tefferi, MD

Blood (2005) 106 (11): 2590.

https://doi.org/10.1182/blood.V106.11.2590.2590

Published: 2005

NARROW

Patient Outcomes after Initial High Dose Versus Low Dose Romiplostim for Inpatient Management of Immune Thrombocytopenia

C3+ and C3- Warm Autoimmune Hemolytic Anemias: A Comparison of Clinical Characteristics and Treatment Outcomes

Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia

Cytogenetics in Essential Thrombocythemia: Phenotype and Molecular Correlates and Prognostic Relevance in 818 Informative Cases

The 1.5 Million Platelet Count Threshold in Essential Thrombocythemia: Phenotype and Genotype Correlates and Relevance to Vascular Events

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Immune-Related Hematologic Adverse Events in the Context of Checkpoint Inhibitors

Utility and Patterns of Vitamin B12 and Folate Testing in Patients with Isolated Thrombocytopenia

Extreme Thrombocytosis: Influence of Care Setting and Likelihood of Occult Malignancy

Clinical and Serological Characteristics of Cold Autoimmune Hemolytic Anemia with Concomitant Cold Agglutinin and Donath-Landsteiner Antibodies

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Accessory Splenectomy for Relapsed Idiopathic Thrombocytopenic Purpura.

Choosing the Right Patients for Clinical Trials in Essential Thrombocythemia or Polycythemia Vera: Leukemic or Fibrotic Transformation Risk Assessment among 1061 Patients from a Single Institution.

A Study of Bedside Visual Art To Decrease Anxiety and Improve Pain and Mood in Cancer Patients: The Mayo Clinic Experience.

Cytogenetic Abnormalities in Essential Thrombocythemia: Prevalence and Prognostic Significance.

MPL 515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?

JAK2 V617F Mutation in Essential Thrombocythemia: Clinical Associations and Long-Term Prognostic Relevance.

Lenalidomide (CC-5013) Treatment for Anemia Associated with Myelofibrosis with Myeloid Metaplasia.

Low Incidence of FIP1L1-PDGFRA in Eosinophilic Patients and Long-Term Experience with Imatinib Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only